Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update

Link to Full Article MARINA DEL REY, Calif., Aug. 14, 2019 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced second quarter results and provided a corporate and clinical update. Key Second Quarter and Subsequent Period Highlights: Successfully completed […]

Micro-encapsulation matters and this $5.5 million infant formula deal proves it

Link to full Article Micro-encapsulation may sound like something that only matters for the highly scientifically-literate. But in a competitive market like infant formula it could make a big difference. Stockhead spoke with both sides of a deal completed last week over this trend. It involves venture capitalists BioScience Managers, which invested $5.5 million in […]

BioScience Managers invests in CSIRO-derived microencapsulation technology

Melbourne, Australia and London, UK 8 August 2019 – BioScience Managers (BSM), one of Australia’s leading international healthcare investment firms, today announces an investment in Sydney-based nutrition technology company, Pharmamark Nutrition Pty. Ltd. BSM has invested A$5.5 million in Pharmamark Nutrition. The funds will go toward the development of CSIRO’s microencapsulation technology for Pharmamark’s IntEncap™ product […]

Leading investment firm invests in new CSIRO health technology

Link to Full Article BioScience Managers (BSM) is one of Australia’s leading international healthcare investment firms. The CSIRO is Australia’s most loved, respected and revered science and research organisation, responsible for fast Wi-Fi, Aerogard and polymer banknotes among many other notable discoveries. Currently it is working on the first gravitational waves in space, growing gluten-free […]

AVITA Medical Reports Fourth Quarter Fiscal 2019 Financial Results and Company Update

Link to Full Article • Total revenue of A$17.0 million for fiscal year 2019 (FY19), an increase of 50% year-over-year • U.S. product sales of A$6.2 million for FY19 • U.S. product sales of A$2.9 million for fourth quarter, an increase of 32% compared to FY third quarter sales Valencia, Calif., USA, and Melbourne, Australia, […]

SYNTHETIC WOUND HEALING MEMBRANE

Link to Full Article ‘Synthetic Amniotic Membrane’ development project supported by InnovateUK and the UKI2S Accelerator Programme for Technology Development Projects. For many of us, there is hardly any more life-changing disability imaginable than loss of sight. Whether through trauma or disease, the inability to rely on visual cues impacts on all matters of daily […]

Regulatory approval next hurdle for Saluda Medical

Link to Full Article Regulatory approval is the next major hurdle facing Saluda Medical, the biotech company which is led by Cochlear’s former chief technology officer and was responsible for the biggest domestic life sciences capital raising of the last fiscal year. Saluda Medical said in June it had raised $US75 million ($106 million) from […]

Data Published in Functional Neurology Demonstrate that Global Kinetics’ Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson’s Disease Patients

Link to Full Article Unlike patient-reported motor diaries, PKG distinguishes among different groups of fluctuators and identifies high levels of dyskinesia among patients who deny having dyskinesia symptoms PORTSMOUTH, NH USA, LONDON, UK and MELBOURNE, Australia, July 23, 2019 – Global Kinetics Corporation Ltd. today announced the publication of a study demonstrating that the use […]

ADC BIO’S NEW STATE OF THE ART CLEAN ROOM FACILITY IS NOW READY TO SERVE GLOBAL CUSTOMER DEMANDS!

Click Link for full Article WHP COMPLETES CLEANROOM PROJECT FOR ADC BIO IN THE UK Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility. The project has been designed and built by WHP. The new GMP cleanroom is part of ADC Bio’s […]

ARECOR SIGNS A NEW FORMULATION EVALUATION AGREEMENT WITH AN EXISTING PARTNER, A MAJOR GLOBAL PHARMACEUTICAL COMPANY

Link to Full Article Cambridge, UK., 9th July 2019: Arecor Ltd (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a further collaboration with a major global pharmaceutical company. Under this […]